Sanofi-Synthélabo to lose anti-takeover defence

Sanofi-Synthélabo, France's second largest pharmaceuticals group, will lose its anti-takeover defence in a year, after its two main shareholders decided to scrap a five-year-old pact.

Total, the oil company, and L'Oréal, the cosmetics group, who between them control a blocking minority in Sanofi-Synthélabo, said this week they would not renew the shareholder pact that they had signed in April 1999, when it expires in December 2004.

WSJ Logo
Pro Bono or Pro Nono? Law Firms Split on Fulfilling Deals With TrumpExternal link

Pro Bono or Pro Nono? Law Firms Split on Fulfilling Deals With Trump